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Abstract
Cancer-related fatigue (CRF) is a persistent and debilitating problem for many breast
cancer survivors. Although many CRF measurement tools are available, no consensus
exists on the most appropriate tool to use for breast cancer survivors. The purpose of this
project was to identify the best method of assessing CRF in breast cancer survivors. The
practice-focused question inquired about the most appropriate way to assess fatigue in
breast cancer survivors. The central concepts of the project were CRF and cancer
survivorship. This project was informed by the theory of health as expanding
consciousness and Mishel’s theory of uncertainty in illness. The sources of evidence
included multi-database searches and literature from professional organizations. Results
were tracked using preferred reporting items for systematic reviews and metasystems and
a literature review matrix. The search identified 14 sources, which were assessed for
quality using the grading of recommendations, assessment, development, and evaluation
process. The results of this systematic review did not support the use of any particular
assessment tool; however, 2 clinical practice guidelines recommended screening using a
numerical severity scale followed by detailed assessment of clinically significant fatigue
using available assessment tools. Screening can be implemented into the survivorship
clinic, allowing nurses to identify potentially clinically significant fatigue so that further
workup is done and interventions are implemented. Identifying, assessing, and
intervening for clinically significant fatigue can improve the quality of life for breast
cancer survivors, contributing to positive social change.
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Section 1: Nature of the Project
Introduction
With advances in treatment, the survival rate for breast cancer is increasing,
creating a large population with unique needs based on what they have been through in
their cancer treatment (Appling, Scarvalone, MacDonald, McBeth, & Helzlsouer, 2012).
Fatigue is one of the most commonly reported symptoms after breast cancer treatment,
negatively affecting the recovery of an estimated 40% of survivors for as long as 10 years
(Appling et al., 2012).
Fatigue itself is a complex concept. It is highly subjective and relies on patient
report of symptoms. Many factors contribute to its severity (e.g., pain, sleep disturbances,
depression, anxiety, decreased physical activity, cognitive problems, weight gain, and
menopausal symptoms). Fatigue can negatively affect quality of life (QOL) and can be
frustrating for patients and providers (Appling et al., 2012). Although many models and
scales are available to measure cancer-related fatigue (CRF) for patients undergoing
active treatment, a lack of consensus exists on an appropriate method to assess this in
breast cancer survivors (Noonan, 2016).
To provide care effectively to breast cancer survivors, nurses need to be able to
perform an evidence-based assessment of fatigue. This project was a systematic review of
the literature in which I provide guidance on the most appropriate method to assess this
complex and persistent symptom. Being able to assess the fatigue adequately is the first
step in developing interventions for the problem. Addressing this prominent problem
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should improve the QOL of breast cancer survivors and contribute to positive social
change.
Problem Statement
Breast cancer is common among American women; 1 in 8 will develop invasive
breast cancer. As of January 2018, an estimated 3.1 million women were living with a
history of breast cancer, and researchers anticipate 266,120 new cases of invasive breast
cancer diagnosed in 2019 (Breastcancer.org, n.d.). Due to increased awareness and early
screening, women are being diagnosed earlier in the disease. Therefore, the mortality due
to breast cancer has been decreasing through the years (Breastcancer.org, n.d.). Similar to
the general trend for the United States, in Arkansas, breast cancer mortality has decreased
steadily in recent years. Regardless of stage at diagnosis, the overall survival rate at 5
years is 77% and at 10 years is 62% (Arkansas Department of Health, 2017).
In a review of CRF by Weis (2011), fatigue was one of the most frequent
symptoms occurring during treatment with prevalence rates ranging from 59 to 100%.
The level of fatigue was higher among long-term survivors than in the general population
and persisted more often with long-term and late effects. CRF negatively affected QOL
by interfering with work life, family life, and sexuality (Weis, 2011). CRF correlates with
sleep disorders (Ryan et al., 2007), and a relationship exists between depression, anxiety,
psychological distress, and CRF (Fabi et al., 2017). CRF has negative consequences for
the patient, the spouse and family, and the health economy as a whole. Cancer patients
suffering from CRF, compared with patients without CRF, sought more health services,
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had higher rates of sick leave, and had more loss of work capacity, with some sufferers
not returning to work (Weis, 2011).
My focus in this project was on the prevalence of CRF interfering with QOL in
breast cancer survivors at Arkansas’s cancer center. There is an ever-increasing number
of breast cancer survivors, and many contend with CRF (Fabi et al., 2017). Therefore, it
is important to have an evidence-based fatigue assessment. The diagnosis of breast cancer
is life changing; the treatment is tedious and damaging, and it can leave a person altered
and physically and emotionally drained. Nurses and health care providers need to address
how best to help patients overcome the challenges of CRF so that they can experience
improved QOL in long-term survivorship (Appling et al., 2012).
The local relevance of the need to address CRF is supported by the Arkansas
Cancer Coalition’s (ACC) report, issued in 2015, outlining the state plan to address
cancer. Among the topics of concern in that report is survivorship care. One objective of
the state plan is to “educate health care providers on their role in survivorship by
addressing cancer survivor’s needs and care-related issues to improve survivorship care”
(ACC, 2015, p. 47). Another objective is to “address the needs of cancer survivors and
their families to improve survivorship care” (ACC, 2015, p. 48). The findings of this
project may be used by health care providers to address the needs of cancer survivors and
educate health care providers on the specific psychosocial needs of this patient
population.
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Purpose Statement
The gap in practice that I addressed in this project is a lack of consensus on a
consistent method of assessing CRF in breast cancer survivors (see Noonan, 2016). My
purpose in this project was to identify the best method of assessing CRF in breast cancer
survivors and develop a plan for dissemination of the findings and implementation in the
survivor clinic. The practice-focused question was the following: What is the most
appropriate way to assess fatigue in breast cancer survivors?
This project has the potential to address the gap in practice. Through my findings,
I have identified an appropriate method for assessing CRF in breast cancer survivors.
This assessment method can then be used by health care providers in clinical practice to
improve care of breast cancer survivors by addressing the prevalent and life-altering
struggle that is CRF. Beyond the scope of this project, the results of this project could aid
in further study of interventions in the treatment of CRF.
Nature of the Doctoral Project
The nature of the project is a systematic review of the evidence. Researchers use
this type of project to create an unbiased, comprehensive summary of the research on a
particular topic (Walden University, 2017b). Specifically, this project was a systematic
review of the literature on the assessment of CRF in breast cancer survivors.
Sources of Evidence
Sources of evidence included textbooks on cancer survivorship and oncology
symptom management. These sources established an understanding of what is known
about CRF assessment. I then conducted a multidatabase search through Thoreau and the
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Walden Library website. Key search terms included CRF and breast cancer survivors.
Inclusion criteria included current (published in 2012 or later), peer-reviewed, scholarly
journals, and professional organizations that specialize in cancer and survivorship. This
included the practice standards and guidelines from organizations such as Oncology
Nursing Society (ONS), American Society of Clinical Oncology (ASCO), National
Comprehensive Cancer Network (NCCN), and Advanced Practice Society for
Hematology and Oncology (APSHO).
Approach
The approach was the structured literature review organized around the central
concept of assessment of CRF. I critically appraised each article or source for its
significance, applicability, clarity in presentation of findings, and quality of research
conducted (see Terry, 2015) and used the GRADE process to classify the quality of the
evidence. This system is widely used by organizations such as the World Health
Organization and the Cochrane Review. The process is explicit and rigorous yet user
friendly, allowing for simplicity and transparency. Each piece of evidence is classified
into one of four levels: high, moderate, low, and very low (Guyatt et al., 2008).
Significance
Stakeholders
Key stakeholders in this practice problem include the patients and health care
providers for breast cancer survivors. The patients will benefit from interventions
directed at managing CRF. The clinical providers will benefit from having clarity on
which evidence-based tool may be appropriate and useful.
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Contribution to Nursing Practice
Evidence suggests that CRF is important to nursing practice. For example, the
Holden Comprehensive Cancer Center at the University of Iowa attempted education and
interventions to address CRF in 1995. Unfortunately, CRF is thought of as an untreatable
and inevitable consequence and is inconsistently addressed and inadequately managed.
Newer efforts (Huether, Abbott, Cullen, Cullen, & Gaarde, 2016) have been implemented
at Holden Comprehensive Cancer Center to have a nurse-led exercise intervention for
cancer survivors. Huether et al. (2016) noted that the oncology nurse is in an excellent
position to assess CRF, educate patients, and follow up with patients to increase
adherence.
Another example, in the National Action Plan for Cancer Survivorship, published
by the Centers for Disease Control and Prevention (CDC) in conjunction with the Lance
Armstrong Foundation, one of the action steps is to establish a base of applied research
and knowledge focusing on the issues of cancer survivors. Another action step is to
implement effective programs to address survivors more completely (CDC, 2004). These
initiatives direct the focus of nursing research. My project is a literature review focused
on CRF in breast cancer patients. The results of this literature review will contribute to
the research and knowledge that is called for in the National Action Plan for Cancer
Survivorship. Similarly, the results of this literature review could help health care
providers in implementing an effective program to address cancer survivor’s needs by
prioritizing the assessment of CRF (Weis, 2011).
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Transferability
The findings of this study have transferability to similar practice areas. CRF is not
an isolated symptom but can have adverse effects on functional status, mood, well-being,
distress level, and sleep (Mitchell, 2015). CRF is highly subjective with some patients
reporting excessive need to rest, whereas others characterize it as loss of efficiency or a
mental fogginess (Mitchell, 2015). The experience of CRF is not isolated to breast cancer
survivors but can occur at any point in the cancer trajectory and can affect cancer
survivors of all types (Kantor & Suzan, 2016). CRF is often underreported and
undertreated. Studies have concluded that one of the reasons for this underreporting and
undertreating stems from difficulties in defining and accurately measuring CRF (James et
al., 2015). The results of this project could be transferred to other disciplines that work
within the multidisciplinary cancer survivor clinic. This includes the social worker,
nutritionist, pastoral care, counselors, and physical therapists. CRF is a multidimensional
problem with physical elements, emotional elements, and cognitive components (James
et al., 2015). Being able to fully assess CRF will allow the different professionals
working with this population to understand the severity of symptoms the patient may be
experiencing. A multidisciplinary approach to treating the CRF can then be created to
address the patient’s individual needs.
Social Change
This project supports the mission of Walden University by promoting positive
social change. The concept of social change refers to the promotion of the “worth,
dignity, and development of individuals” (Walden University, 2017a). Persistent CRF
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can negatively affect the cancer survivor’s well-being and QOL (Mitchell, 2015).
Therefore, CRF influences the individual’s perception of self-worth and dignity. By
accurately assessing and measuring CRF in breast cancer survivors, health care providers
can then use these measures to determine efficacy of interventions.
Summary
Breast cancer survivors are a growing population with unique needs. CRF is a
prevalent symptom in this population and can negatively affect QOL (Appling et al.,
2012). Researchers have studied CRF and assessment strategies have been proposed, but
consensus does not exist on the ideal assessment strategy for the survivor population
(Noonan, 2016). Through this project, which is a systematic review of the literature, I
will aid in identifying an appropriate assessment method. Once identified, this assessment
method can be implemented into clinical practice. Giving nurses the tool to assess CRF is
the first step in the nursing process. In the next section, I will discuss, in further detail,
the background, supporting theories, relevance, context, and roles.
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Section 2: Background and Context
Introduction
There is an ever-growing population of breast cancer survivors with a unique set
of clinical needs. A prevalent symptom in this group of patients is persistent CRF (Wang
& Woodruff, 2015). However, currently no consensus exists on the best method of
assessing CRF in breast cancer survivors (Noonan, 2016). Therefore, my purpose in this
project was to identify the best method of assessing CRF in breast cancers survivors and
to develop a plan for dissemination of findings and implementation in the survivor clinic.
The practice-focused question was: What is the most appropriate way to assess fatigue in
breast cancer survivors?
In the first section of Section 1, I discuss relevant theories and models that I used
to understand my research problem; I also provide definitions of important concepts.
Second, I present of the relevance of this project to nursing practice in general. Third, I
provide a description of the local context. Last, I discuss my role as a doctor of nursing
practice (DNP) student, including my motivations and potential biases.
Concepts
Two key concepts were central to this project: CRF and cancer survivorship. The
backbone of any scholarly project is the core concepts of interest because concepts are
the building blocks of models and theories. The operational definition of a concept must
be clear so that the connections between the concepts can be made (Doyle, 2008). The
following is a summary of concept analyses for CRF and cancer survivorship. These are
the 2 key concepts in the practice-focused question, central to the project.
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Cancer-Related Fatigue
Historically, the concept of CRF has been difficult to clarify. This lack of
clarification has resulted in inconsistencies in the definition and the instruments proposed
to measure CRF. Fatigue is a common symptom of illness in general, not only of cancer,
and has been used interchangeably and erroneously with tiredness or weakness (Ream &
Richardson, 1996). Further study has characterized CRF as feelings of tiredness,
weakness, and lack of energy. In addition, CRF interferes with usual functioning and
QOL and does not correlate with the level of exertion (Hofman, Ryan, Figueroa-Moseley,
Jean-Pierre, & Morrow, 2007). CRF is complex, subjective, and multidimensional, and it
is best measured by self-report from patients (Ream & Richardson, 1996).
For this project, I used a recent definition proposed by ASCO. CRF is “a
distressing, persistent, subjective sense of physical, emotional, and/or cognitive tiredness
or exhaustion related to cancer and/or cancer treatment that is not proportional to recent
activity and interferes with usual functioning” (Bower et al., 2014, p. 1844). This
definition combines an understanding of the many attributes of CRF as well as the
potential ramifications in all areas of life. This definition also highlights the subjective
nature of CRF and that it affects patients’ functioning in daily life and must be addressed
by clinicians (Bower et al., 2014).
Cancer Survivorship
The second concept that requires precise definition for my project is cancer
survivorship. Attention to cancer survivorship is credited to physician and cancer
survivor Mullan. In the book, Seasons of Survival, the author described three periods in
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survivorship: acute, extended, and permanent (1985). Survivorship begins with diagnosis
and continues for the remainder of life (Doyle, 2008). Further definitions of this concept
extended the criteria to inclusion of caregivers, friends, and family because of the effects
of cancer diagnosis and treatment on them by proxy of their loved ones. Often, an
undercurrent of battle themes occurs in discussions of survivorship, described as
‘winning the fight’ against cancer (Hebdon, Foli, & McComb, 2015).
For the purposes of this project, I used the following definition that has been
proposed by the National Coalition for Cancer Survivorship (NCCS). NCCS defines
someone as a cancer survivor from the “time of diagnosis and for the balance of life
[and] to include family, friends, and caregivers” (Twombly, 2004, para. 6). This
definition is concise, accepted widely by the cancer community, and endorsed by ASCO
(ASCO, n.d.).
With improvements in screening, early detection, and treatment, there is an everincreasing cancer survivor population. This has created a shift in perspective regarding
cancer survivorship. For example, breast cancer is no longer a completely fatal disease.
Cancer survivorship is considered, by clinicians, to be a long-term chronic disease
(Cheung & Delfabbro, 2016). As with any chronic disease, patients can experience a
wide range of issues and challenges. Cancer survivors may experience persistent fatigue,
physical changes, fear of recurrence, late- and long-term effects of cancer treatment, and
an expectation to get back to ‘normal.’ During survivorship, the patient is no longer in
active treatment and therefore no longer being seen by the treatment team on a regular
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basis; this reduction in care can be experienced as a removal of a perceived ‘safety net’
(Kantor & Suzan, 2016).
There is a growing focus on understanding and addressing survivorship. This
focus stems from the many health problems that survivors can face as a consequence of
their illness, their treatment, pre-existing conditions, and normal aging-related changes.
To support the complex care of cancer survivors, ASCO published The Survivorship
Curriculum (2016). The curriculum outlines the essential elements of survivorship care
including surveillance for recurrence and second cancers, treatment of long-term and late
effects of cancer treatments, health promotion and disease prevention, psychosocial wellbeing, and communication and care coordination (Shapiro et al., 2016).
CRF is a common and disruptive symptom experienced by cancer survivors. The
source of the fatigue is not clear. It could be a consequence of the cancer itself, or the
treatments, but generally resolves after end of treatment and cure of cancer (Corbett,
Groarke, Walsh, & McGuire, 2016). However, it is estimated that at least 30% of cancer
survivors struggle with CRF for years after completing treatment for their cancer.
Patients report not being prepared for the experience of persistent fatigue often leading to
confusion, isolation, and frustration (Corbett et al, 2016).
Theory
Health as Expanding Consciousness
The Health as Expanding Consciousness theory was developed by Newman and
stems from Rogers’s theory of unitary human beings (Petiprin, 2016). The theory
proposes that defining health as the absence of disease is problematic because some
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individuals must deal with chronic diseases, so absence of a disease is not a possibility.
Yet, health, or thinking of oneself as healthy, should be a possibility for all individuals.
Theorists of HEC posit that every person, regardless of disease status, is part of the
universal process of expanding consciousness (Petiprin, 2016). This expanding
consciousness, according to the theory, leads to a better understanding of oneself, finding
greater meaning in life, and connecting with the others and the world. Within the HEC
and the unitary-transformative paradigm, nursing is an opportunity to partner with
patients and their families and participate in transformative encounters (Doyle, 2008).
In a concept analysis of cancer survivorship, Doyle (2008) applied HEC to the
cancer survivorship period. Describing survivorship as a process that starts at diagnosis
and extends past treatment. The survivorship period and process can allow for a new
synthesized view of self, incorporating chronic illness and disease as a meaningful aspect
of health (Doyle, 2008).
Cancer survivors are living with a chronic disease. Yet, according to HEC,
survivors can view themselves as healthy (Petiprin, 2016). Cancer survivors can
participate in the universal process of expanding consciousness and thus be able to find
greater meaning in their life and reconnect with the world around them, regardless of
disease state (Kantor & Suzan, 2016). Nurses can engage with patients about their
experience within the context of expanding consciousness helping the patient cope and
recover.
In 1990, Newman developed a research method based on HEC called the praxis
method. The focus within the praxis method is the integration of theory, research, and
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practice into a unitary perspective. It requires the researcher-practitioner to be
authentically present with the client-participant in searching for life patterning (Smith,
2011). Research using HEC and the praxis method is growing and is being used
internationally, indicating a global appeal and that the concepts in the theory transcend
cultural differences (Endo, Miyahara, Suzuki, & Ohmasa, 2005; Smith, 2011).
HEC has been used to study many chronic illness and distressing situations. These
include the study of coronary heart disease, HIV/AIDs, COPD, rheumatoid arthritis,
multiple sclerosis, schizophrenia, weight loss, dementia, bipolar disease, menopause,
smoking cessation, and health care disparities. This range of focuses indicates that HEC
is widely applicable in nursing (Smith, 2011).
Moch (1990) used HEC to explore the experience of health for patients with
breast cancer. Patterns of expanding consciousness emerged as a result of the tension
created by illness. This expanding consciousness then facilitated change and
connectedness between the person and environment (as cited in Smith, 2011, p. 264).
Newman (1995) used HEC to explore the meaning of the life pattern of persons
diagnosed with cancer. The diagnosis of cancer in these patients led to a turning point in
life that, for some, resulted in authentic living and more meaningful connections with
others (as cited in Smith, 2011, p. 264). Karlan, Jankowski, and Beal (1998) used HEC to
explore the experiences of childhood cancer survivors. The experience of cancer as a
child promoted expanded consciousness and life patterns of hope, optimism, empathy,
and family bonds (as cited in Smith, 2011, p. 265). Kiser-Larson (2002) used HEC to
understand life patterning in Native American women with breast cancer. The diagnosis,
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for these women, led to chaos and a turning point that led them to deeper meaning in life
and spirituality (as cited in Smith, 2011, p. 267).
Endo has used HEC in the study of cancer and the nurse-client relationship
(1998), family-nurse relationship (2000), praxis methods (2005), and smoking cessation
(2009) (Smith, 2011). Endo (2017) specifically applied HEC to cancer and the nursing
process. The nurse, or provider, and the patient enter into a mutual process of pattern
recognition leading to a higher level of consciousness. This is called the ‘caring
partnership,’ which then facilitates the development of interventions that focus on the
patient as a whole and the patient’s meaning in the experience. The caring partnership is
recommended to nurses and doctors who care for cancer patients. The partnership will
lead to better understanding by both parties and personal growth through difficult
situations (Endo, 2017).
Mishel’s Theory of Uncertainty in Illness
Cancer survivors experience uncertainty about their disease and its potential
trajectory, what extended survival will look like and the ever present fear of recurrence.
There is ambiguity surrounding this chronic illness state, complicated by treatments,
information gaps, and unpredictable disease course. This uncertainty may lead to positive
or negative coping strategies (Hebdon et al., 2015).
This uncertainty is explained by Mishel’s uncertainty in illness theory. Developed
by Mishel in the 1980s, the theory attempts to address the issue of uncertainty in chronic
illness and coping with that uncertainty. The theory posits that uncertainty in illness can
be viewed as a threat or an opportunity, leading to positive and/or negative coping
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strategies to reduce the threat and/or enhance the opportunity. Mishel further stated that
accepting uncertainty as a fluid state and view it as leading to more possibilities and new
patterns of thinking in living is essential to coping with chronic illness (Mishel, 1990).
The theory of uncertainty in illness has been studied extensively in many illness
states to include heart transplant, myocardial infarction, cardiac surgery, bowel resection,
COPD, cystic fibrosis, scoliosis, end-stage renal disease, and multiple sclerosis. It has
been studied in children, adolescents, and adults with cancer and among cancer survivors.
(Neville, 2003). The perception of uncertainty is identified as one of the major problems
of cancer survivors. This uncertainty can influence stress appraisal, coping, and hope
(Wonghongkul, Moore, Musil, Schneider, & Deimling, 2000). Uncertainty may become
integrated into daily existence and has been associated with poorer QOL in breast cancer
survivors (Tramm, McCarthy, & Yates, 2012).
Wonghongkul, Dechaprom, Phumivichuvate, and Losawatkul (2006) investigated
the relationship between uncertainty, coping, and QOL among early (3 years after
diagnosis) breast cancer survivors. A moderate level of uncertainty was found among the
participant and the longer the survival time the less uncertainty they reported. Uncertainty
can be mitigated by education, familiarity, and social support (Wonghongkul,
Dechaprom, Phumivichuvate, & Losawatkul, 2006). Miller (2014) applied the theory of
uncertainty in illness to information seeking in cancer survivorship. The chronic presence
of uncertainty in cancer survivorship can lead to or contribute to distress for the patient
and the patient’s family and caregivers. Communication with the health care team can
reduce uncertainty but too much information can complicate the uncertainty (Miller,
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2014). Therefore it is imperative for nurses and providers to establish a relationship with
patients, to understand their unique information needs. This facilitates viewing
uncertainty as more possibilities rather than a threat (Mishel, 1990).
Both the HEC and the theory of uncertainty in illness focus on building
relationships with patients to help them better understand their chronic illness and then
better cope with the consequences of the disease (Endo, 2017; Miller, 2014). Both
theories are applicable to the study of CRF. Using the HEC nurses can form caring
partnerships with cancer survivors to explore the meaning of the fatigue according to the
patient. Then using, the theory of uncertainty in illness, nurses can help the patients
understand the fatigue and its source then work together to build a care plan to aid in
coping and recovery.
Relevance to Nursing Practice
Cancer survivorship is a relevant issue to nursing practice because of the
increasing number of cancer survivors. The American Cancer Society estimates that more
than 1.3 million people were diagnosed with cancer in 2005 (Hofman et al., 2007). This
number is still increasing. In 2012, approximately 13.7 million people were living with a
history of cancer. This is projected to increase to 18 million by 2022 (Hebdon et al.,
2015). The growing prevalence of patients with a history of cancer presents new
challenges for nursing practice to “identify and manage treatment-related sequelae,
enhance QOL, and improve the overall functioning” (Jones et al., 2016, p. 52).
In a survey of 763 breast cancer survivors 35% reported experiencing fatigue at
1-5 years post-treatment, 34% at 5-10 years post-treatment, and 21% report experiencing
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fatigue at both measurement points (Hofman et al., 2007). Fatigue is a persistent,
debilitating, distressing symptom in a significant portion of cancer survivors (Hofman et
al., 2007). Similarly, in a study of fatigue and disability Jones et al. (2016) found that
CRF was still present 6 years post-treatment and was most common among breast and
colorectal cancer survivors. CRF is reported by survivors as the most distressing
symptom, having greater negative effect on cancer survivors’ QOL than pain, depression,
and nausea. In addition, other complications of fatigue include: impairment in ability to
perform activities of daily living, increased levels of anxiety, mood disturbance, loss of
work days for patients, family members, and care givers (Hofman et al., 2007). Research
suggests that cancer survivors utilize primary care more frequently than age-matched
controls and use it for the primary complaint of fatigue. Still, CRF is underreported,
underestimated, and undertreated and represents a poorly managed problem for cancer
survivors (Jones et al., 2016).
The Institute of Medicine (IOM) issued a mandate to nurses to “promote
evidence-based, comprehensive, compassionate, and coordinated survivorship care”
(Hewitt, Greenfield, & Stovall, 2005). Surviving cancer is now a reality for millions of
people and fatigue is a significant and distressing for these millions (Shapiro, et al.,
2016). In order to fulfill the IOM’s mandate for ‘comprehensive’ survivorship care,
nursing care must address CRF. Unfortunately, there is no single standardized CRF
measure for breast cancer survivors that has been widely adopted (Wang & Woodruff,
2015).
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CRF is not a new practice issue for nurses. Previously, there have been attempts
to address this problem. One of the first fatigue assessment scales is the Symptom
Distress Scale, developed in 1978. This scale consists of a 13-item self-report Likert scale
for characterizations of multiple cancer related symptoms to include fatigue but also pain,
insomnia, activity, concentration, mood, and appearance. More focused assessments were
also developed such as the Fatigue Scale and Fatigue Observation Checklist ( in 1982),
the Piper Fatigue Scale (in 1989), the Multidimensional Assessment of Fatigue (in 1991),
and the Visual Analog Scale for Fatigue (in 1999). These tools vary in construction,
number of items, and the type of scale used. There are barriers to consistent selection
among these scales such as: measurement model for statistical analysis, evidence of
validity, practicality, psychometric soundness, ease of understanding, ease of use, and
standardized rules for administration and scoring (Wang & Woodruff, 2015). Other
fatigue scales include the Fatigue Symptom Inventory (FSI), the Medical Outcome Study
Short Form-36 Health Survey, and the Profile of Mood States (POMS). However, it is
unclear which of these scales is the best instrument for detection of CRF in active cancer
patients as well as cancer survivors (Goedendorp, Jacobsen, & Andrykowski, 2016).
Patients are unaware of the potential long-term effects of cancer treatment on their
lives and there is need for high quality care after the active treatment phase (James et al.,
2015). The physiology and psychosocial burden of fatigue for cancer survivors is high,
leading to increased disability that has a negative effect on QOL and ability to perform
normal daily activities and be active participants in life. Disability is as important as
mortality and cancer research efforts have reduced mortality, but not the morbidity
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associated with the disability of CRF. Further efforts are needed to detect and treat the
persistent and late effects of cancer (Jones et al., 2016).
Local Background and Context
Hebdon (2015) identified 3 P’s of cancer survivorship care: palliation of
symptoms, prevention of recurrence and late effects, and promotion of wellness.
Addressing CRF serves to fulfill all of the 3 P’s of survivorship. In 2015, a pilot study
was conducted to identify factors contributing to diminished sexual functioning in breast
cancer survivors (Makhoul et al., 2016). The researchers surveyed survivors and their
partners to discover what potential late and long-term effects may be effecting QOL.
They discovered that one of the most reported symptoms affecting sexual function was
fatigue (Makhoul et al., 2016). Fatigue as a contributing factor to sexual dysfunction was
not the expected outcome. There was not specific interest in CRF but rather interest into
QOL and sexual functioning.
Nurses play a key role in the management of fatigue through promoting open
communication between patients and clinical providers. This helps to identify the
problem, reduce anxiety, explore the disease process, set realistic expectations, and helps
to promote meaningful interactions with dignity (Kantor & Suzan, 2016). The cause of
CRF is multifactorial and complex with components of pathology, psychology, situation,
metabolism, and mood disturbance (Jones et al., 2016). This project will help nurses
fulfill their role in the management of CRF by helping nurses to identify the problem and
explore the disease process through the assessment of CRF. Also, this project will
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provide a consistent way to monitor the effectiveness of interventions aimed at
addressing CRF.
The state’s medical oncology division at the cancer center participates in ASCO
Quality Oncology Practice Initiative (QOPI). This program helps to promote a culture of
improvement within the outpatient oncology practice. Participants can report on certain
quality measures and become QOPI certified. These quality measures can be used as a
measure of performance and can aid in the development and implementation of quality
improvement projects leading to better outcomes and better patient care (ASCO.org,
2018). One of the quality domains reported to QOPI and used for certification
designation is reporting on efforts for symptom management for breast cancer survivors.
CRF is a symptom in breast cancer survivors and the results of this project will aid nurses
in the assessment of CRF, thus improving the quality of care for the breast cancer
survivors at this site and meeting the criteria for QOPI.
ASCO, NCCN, and the Canadian Association of Psychosocial Oncology (CAPO)
have developed guidelines on the treatment of CRF during active treatment. It should be
routinely assessed and measured on a scale of 0-10 with a cutoff of 4 signaling more
action needed. Treatment starts with a comprehensive assessment of all contributing
factors, specifically functional status, nutrition, exercise, and sleep. Approaches to
mitigate CRF include patient education, cognitive behavioral therapy, sleep hygiene, and
physical activity. There is no consensus on the best measurement of CRF and its
multifactorial origins, nor is there consensus on the gold standard of treatment (Jones et
al., 2016).
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Treatment of CRF can be costly and time consuming. It is important to be mindful
of resources in health care. Therefore it is important to be able to identify clinically
significant cases of CRF. This will enable nurses to target those patients in need of
treatment for CRF. A method for efficiently and accurately screening large patient
populations such as cancer survivors is needed (Goedendorp et al., 2016).
Also, the state’s cancer center is striving for National Cancer Institute (NCI)
accreditation. This is a rigorous accreditation process that recognizes the cancer center as
prestigious and contributes to its support, funding, and increased access to clinical trials.
To become accredited a cancer center must prove that it is contributing to the fight
against cancer and be a center for ground-breaking treatments and quality care for the
community (“NCI-Designated Cancer Centers”, n.d.). This project contributes to the NCI
accreditation effort in that the results will help to improve the quality of care for the
community by improving the assessment of CRF in breast cancer survivors.
Role of the DNP Student
My professional context is that I am the advanced practice registered nurse
(APRN) in the UAMS-WPRCI survivor clinic. I am charged with addressing the 3 P’s of
cancer survivorship for my patients who come from all over the state of Arkansas. My
relationship or role in the doctoral project is that I will be conducting the systematic
review of the literature. This topic is important to me because it is integral in addressing
QOL for my patients. I am a member of the ACC and am passionate about improving the
lives of cancer survivors in Arkansas. My professional mentor was the primary
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investigator in the previously mentioned pilot project conducted at UAMS and is the one
who brought this issue to my attention.
Any researcher or project is subject to potential bias. Bias is “any tendency to
which prevents unprejudiced consideration of a question” (Pannucci & Wilkins, 2010, p.
1). This can occur in any phase from planning, to data collection, to interpretation. It is
important not only to ask if bias is present or not but to consider how it can be prevented
by proper design and diligent implementation (Pannucci & Wilkins, 2010). The design of
this project is a systematic review of the literature. There is potential for inherent bias
with this type of project in the selective inclusion or exclusion of studies to support the
authors’ views. To reduce the potential for bias it is important to follow a structured,
transparent, and recorded process. In this way, any other reviewer could follow the same
steps, with the same resources, and reach the same conclusions (Walden University,
2017b).
Summary
In this section of the paper, I defined the concepts that are central to the project.
As well as the underlying theories. Then, I expanded on the relevance to nursing practice
as well as the local background and context. Finally, I clarified my role as the DNP
student, including motivations and potential biases. In the next section, I will address the
practice-focused question, the sources of evidence that I used including published
resources and outcomes, and the systems that I used for data analysis and synthesis.
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Section 3: Collection and Analysis of Evidence
Introduction
The problem that I addressed in this project is that no consensus exists on the best
method of assessing CRF in breast cancer survivors. Many models and scales are
available to measure CRF for patients on active treatment but not for survivors (Noonan,
2016). CRF is one of the most commonly reported symptoms for breast cancer survivors
and can negatively affect QOL and coping for patients and families (Appling et al.,
2012). My purpose in this project was to conduct a systematic review of the literature to
identify the best method of assessing CRF in breast cancer survivors and to develop a
plan for dissemination of the findings for implementation in the survivor clinic.
Due in part to better screening, early detection, and improved treatments, there is
an ever-increasing number of cancer survivors. The American Cancer Society estimates
that 18 million people will be living with a history of cancer by the year 2022 (Hebdon et
al., 2015). Fatigue is a persistent, debilitating, distressing symptoms in a significant
portion of cancer survivors (Hofman et al., 2007). The IOM issued a mandate to nurses to
“promote evidence-based, comprehensive, compassionate, and coordinated survivorship
care” (Hewitt et al., 2005, p.19). To fulfill this mandate and provide quality patient care
to the unique population of cancer survivors, nurses need a tool to properly assess CRF.
In Section 3, I reiterate the practice-focused question and the gap in practice that I
addressed in this project. I clarify the purpose, alignment, operational definitions, and key
aspects of the project. Further, I elaborate on the sources of evidence, data collection, and
analysis methods. Finally, I describe the system for organizing and tracking the evidence.
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Practice-Focused Question
The practice-focused question that I addressed in this study was the following:
What is the best method to assess CRF in breast cancer survivors? A pilot study of breast
cancer survivors and their partners found that fatigue is one of the most reported
symptoms negatively affecting sexual functioning and QOL (Makhoul et al., 2016).
These results illuminated a gap-in-practice in the management of CRF. Nurses play a key
role in the management of fatigue by promoting open communication between patients
and clinical providers to identify the problem, reduce anxiety, explore the disease
process, set realistic expectations, and promote meaningful interactions and dignity
(Kantor & Suzan, 2016). The results of this project will help nurses fulfill their role in the
management of CRF.
My purpose in this project was to identify the best method of assessing CRF in
breast cancer survivors and to develop a plan for dissemination of the findings and
implementation in the survivor clinic. Identifying the best method of assessment for this
population will enable nurses to identify the problem, better explore the disease process,
and provide a consistent way to monitor the effectiveness of interventions aimed at
addressing CRF. The approach that I used for this project was a systematic review of the
literature organized around the central concepts of CRF and breast cancer survivors.
For the purposes of this project, CRF was defined as “a distressing, persistent,
subjective sense of physical, emotional, and/or cognitive tiredness or exhaustion related
to cancer and/or cancer treatment that is not proportional to recent activity and interferes
with usual functioning (Bower et al., 2014, p. 1844).” The term cancer survivor as
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defined by NCCS is someone from the “time of diagnosis and for the balance of life,”
and “to include family, friends, and caregivers” (Twombly, 2004, para. 6).
Sources of Evidence
Many potential sources of evidence exist to address this question. First, textbooks
have been written on survivorship care and oncology symptom management. These were
a foundational source to establish what is already known on the topic of CRF. The
bibliography sections of these texts also provided further background literature to allow
me to fully understand the scope of the problem and what has been done so far to address
the problem. The next step was to conduct a multidatabase search through Thoreau and
the Walden Library. This provided the bulk of the literature for the systematic review. It
clarified what is being done now to address the problem and what assessment methods
are being used. Finally, I consulted the websites of various professional organizations for
practice standards and guidelines, for example, ONS, ASCO, NCCN, and APSHO. I
included these guidelines in the systematic review and highlighted what experts in the
field view as the appropriate standard of care for the problem.
Published Outcomes and Research
For this systematic review, I followed the steps detailed in the Walden University
manual for systematic reviews. The first step was to identify the scope of the review; this
included the list of databases and search engines, key search terms, scope of review, and
clarity on how the search would be exhaustive and comprehensive (Walden, 2017b). I
accessed the databases through the Walden Library’s Thoreau multidatabase search tool.
Available databases included CINAHL, MEDLINE, Ovid, ProQuest, PubMed, Annual
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Reviews, BioMedCentral, Cochrane, ScienceDirect, Database of Systematic Reviews,
Joanna Briggs Institute EBP Database, Merck Manual, and the Directory of Open Access
Journals.
The Google search engine proved helpful to explore the NCCN, ASCO, ONS, and
the APSHO guidelines. I also used Google Scholar to search for guidelines and articles.
Key search terms included cancer-related fatigue OR cancer related fatigue AND breast
cancer survivor AND assessment. Literature included in the review was published within
the last 5 years, in English, and with full text available. Sources included peer-reviewed
scholarly journals and professional organizations published guidelines. The search was
exhaustive and comprehensive in that I continued until I found no new results, indicating
saturation in the searches.
The second step was to formulate the review question (Walden, 2017b): What is
the best assessment method of CRF in breast cancer survivors? The third step was to
define explicit inclusion and exclusion criteria. The exclusion criteria consisted of no free
full text available, being written in a foreign language, being older than 5 years, and not
using a fatigue measurement instrument.
The fourth step was to perform a comprehensive search to find all relevant
studies. In this step, the systems used for recording, tracking, and organizing the evidence
and the procedure must be explicit to assure the integrity of the evidence (Walden,
2017b). The system for recording and tracking the evidence is the PRISMA flow diagram
(see Appendix A). PRISMA stands for Preferred Reporting Items of Systematic reviews
and Meta-Analyses. Developed by an international work group of researchers to address
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the quality of reporting of results of systematic reviews and meta-analyses, this reporting
system consists of a checklist and four-phase flow diagram to display the flow of
literature through the systematic review process. It is not a quality assessment tool
(Moher et al., 2015).
A systematic review of the literature is not a summary of research articles but a
synthesis of ideas and themes from the literature. The system for organizing the evidence
was a literature review matrix, which aids in creating a comprehensive, fair, and balanced
literature review. This technique can help identify gaps in research and identify diverse or
conflicting findings (Clark & Buckley, 2017). I created the matrix in Microsoft Excel and
included columns for details such as title, author, year, publication, database, DOI,
keywords, summary, strengths, weaknesses, and the reference as well as common themes
and main ideas. In addition, I stored each source and reference in Mendeley citation
management software (see Appendix B).
Analysis and Synthesis
The fifth step for a systematic review was to select the studies, and then the sixth
step was to appraise the studies for quality (Walden University, 2017b). Failure to
recognize and differentiate between high- and low-quality evidence can contribute to
errors in the care and management of patients. Judgment is needed in the interpretation of
evidence, and the GRADE method can help in this interpretation (Guyatt et al., 2008).
Therefore, I analyzed the literature that I discovered in this review using the GRADE
method.
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GRADE is a process for addressing the quality of the evidence and strength of the
evidence. Some advantages of GRADE include that it addresses quality and strength,
provides explicit criteria for each level of evidence, delineates a transparent process,
allows for clear interpretation of strong versus weak evidence and is useful for multiple
types of evidence and studies such as the systematic review (Guyatt et al., 2008). Using
the GRADE method, the researcher classifies each piece of evidence into one of four
levels of evidence: high, moderate, low, and very low (Guyatt et al., 2008). High-quality
evidence means that further research is not likely to change the confidence in the
evidence (Guyatt et al., 2008). Moderate-quality evidence means further research is likely
to affect the confidence in the evidence (Guyatt et al., 2008). Low-quality, sometimes
combined with very low-quality, evidence means that further research is very likely to
change the confidence level in the evidence (Guyatt et al., 2008).
GRADE has been adopted by more than 100 organizations globally, including the
World Health Organization, National Institute for Health and Care Excellence, and the
European Union (EU). For example, the EU used GRADE to develop the Evidence to
Decision (EtD) framework to support the process of going from evidence to decisions.
The EtD framework based on the GRADE method is a transparent, systematic, and
explicit process for judging the evidence (Alonso-Coello et al., 2016).
I completed the remaining steps in the literature review process at the same time
that I filled out the literature review matrix and applied the GRADE criteria. These steps
include (a) identify what is known on the topic, (b) analyze relevant studies, (c)
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summarize and GRADE studies in the review matrix, (d) synthesize the results, (e)
interpret the results, and finally (f) present the results (Walden University, 2017b).
Summary
To improve the care provided to breast cancer survivors, it is imperative for
nurses to address their patients’ needs. One of the most persistent distressing issues
facing these patients is CRF. A method to adequately assess this issue is needed. This
project was a systematic review of the literature to identify the best method of assessing
CRF. Using multidatabase searches, search engines, and library resources I gathered and
organized the evidence then analyzed the evidence using GRADE criteria.
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Section 4: Findings and Recommendations
Introduction
CRF is often described as an “overwhelming or all-embracing feeling of tiredness,
weariness, exhaustion, and malaise which usually cannot be relieved by sleep or rest”
(James et al., p. 2089, 2015). CRF is a debilitating and persistent symptom into the
survivorship period negatively effecting QOL (Mitchell, 2015). To provide effective care
to breast cancer survivors, nurses need to be able to identify significant cases of fatigue
and perform an evidence-based assessment of fatigue. Although many models and scales
are available to measure CRF for patients undergoing active treatment, a lack of
consensus exists on an appropriate method to assess CRF in breast cancer survivors
(Noonan, 2016). This represents a gap in practice. This project is a systematic review of
the literature whose purpose is to address this gap in practice and to answer the practicefocused question: What is the best method to assess CRF in breast cancer survivors?
The sources of evidence for this systematic review of the literature include
multiple scientific databases accessed through Walden Library’s Thoreau search tool and
published guidelines from professional organizations. After obtaining the evidence online
following a logical PRISMA flow diagram, I organized the evidence in a literature review
matrix and analyzed it using GRADE criteria. I managed the citations using Mendeley
software.
Findings and Implications
The Thoreau search criteria included the terms cancer-related fatigue OR cancer
related fatigue AND breast cancer survivor AND assessment. The search mode was
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Boolean with limits set at full text available, published in 2012 or after, peer-reviewed,
academic journals, and available in English. In this search, I found 17 articles. I found an
additional seven records through the websites of the ONS, ASCO, NCCN, and Cochrane
review. After removing duplicate records, 23 remained. I then screened these 23 and
removed nine records. Two records removed for being focused on health-related QOL
and not on fatigue. Two others removed for being examples of fatigue scales and not
examples of their use. One record excluded for focusing on the etiology of CRF, 1 for
focus on cancer-related cognitive impairment, 1 for focus on measuring acupuncture
dose, and 1 for measuring inflammatory markers. Finally, 1 excluded because free full
text was not available (see Appendix A). I then entered the remaining 14 into the
literature review matrix (see Appendix B). In the following sections, I provide a
description of each fatigue assessment tool and the article found in the literature review
that used said tool.
Profile of Mood States
The POMS scale, originally developed in 1971 and consisting of 65 self-report
items, each rate 0 (not at all) to 4 (extremely) (Spielberger, 1972). The items are divided
into six subscales: tension-anxiety, depression-dejection, anger-hostility, fatigue-inertia,
vigor-activity, and confusion-bewilderment. Administration time for healthy adults is 3 to
7 minutes and for ill adults 15 to 20 minutes (Sacham, 1983). Internal consistency is
Cronbach alpha 0.63 to 0.96. Correlation between subscales and total score was 0.84
(Spielberger, 1972). Sacham (1983) abbreviated the scale into a short form of 37 items.
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This decreased the administration time by half while maintaining internal consistency
(Sacham, 1983).
Goedendorp et al. (2016) used a cross-sectional analysis to determine the optimal
cutoff scores for fatigue screening on the Medical Outcomes Study Short Form- 36 (SF36), FSI, and the POMS-fatigue. On the POMS-fatigue, higher scores mean greater
fatigue. Goedendorp et al. concluded that brief, accurate screening can be done using
POMS but that the FSI was found to be most accurate. Limitations include a homogenous
sample and that the results were cross-validated using the same data from different time
points (Goedendorp et al., 2016).
36-Item Short Form
The 36-item short-form (SF-36), developed for the Medical Outcomes Study by
RAND health care in 1992, includes eight multiitem subscales (Ware & Sherbourne,
1992). These subscales measure aspects of fatigue that include physical functioning, role
limitations because of physical health problems, bodily pain, social functioning, mental
health, role limitations because of emotional problems, vitality, and general health
perceptions (Ware & Sherbourne, 1992). The scale can be self-administered or
administered by a clinician. Each item is rated on a Likert scale using summated ratings.
For healthy adults, the form can be completed in 5 to 10 minutes (Ware & Sherbourne,
1992). Other measures of QOL include the 12- and 20-item short forms. All are derived
from the core survey instrument of 116 measures of QOL and functioning (RAND
Corporation, n.d.).
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Again, Goedendorp et al. (2016) used a cross-sectional analysis to determine the
optimal cutoff scores for fatigue screening on the SF-36, FSI, and the POMS-fatigue. The
SF-36 measures vitality, and a lower score means less vitality, which is then interpreted
as fatigue. Goedendorp et al. determined that brief, accurate screening can be done using
SF-36 but, again, that the FSI was most accurate. The researchers also found that a
limitation of the SF-36 is that is has reverse-worded items (Goedendorp et al., 2016).
Functional Assessment of Cancer Therapy
The Functional Assessment of Cancer Therapy (FACT), developed in 1994,
measurement system is a component system consisting of a general scale (FACT-G) that
measures health-related QOL and then disease-specific and symptom-specific subscales
such as the fatigue subscale (FACT-F) (Yellen et al., 1997). FACT-G consists of 28
items, self-report format, measured on a 5-point Likert scale. The questions assess
physical well-being, social/family well-being, relationship with physician, emotional
well-being, and functional well-being (Yellen et al., 1997). FACT-F consists of the
original 34 items plus 13 items specific to fatigue. The combined scale has test-retest
reliability of 0.87 and internal consistency with alphas = 0.95 (Yellen et al., 1997). The
scale has been found especially useful in identifying the physical and functional
component of fatigue (Yellen et al., 1997).
Kaur, Gupta, Sharma, and Jain (2018) conducted a cross-sectional study to
illuminate survivorship issues among Indian breast cancer survivors and effects on QOL.
The fatigue measurement tool was the Functional Assessment of Cancer Therapy-Breast
(FACT-B). This questionnaire consists of the FACT tool plus a fifth subscale specifically
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for breast cancer and consisting of nine items. Kaur et al. found the most commonly
reported survivorship issues include fatigue, shoulder restriction, body pain, joint pain,
loss of sex drive, and chemotherapy-induced amenorrhea. This study, although the first to
study this population, was more focused on overall QOL rather than CRF. Other
limitations include the hospital setting limiting generalization to the ambulatory setting
and being cross sectional, therefore lending no longitudinal data (Kaur et al., 2018).
Revised Piper Fatigue Scale
The revised Piper Fatigue Scale (PFS), developed by Piper in the 1997 as a
shortened version of the original multidimensional PFS, contains 22 items in four
subscales (Piper et al., 1998). These subscales look into the multidimensionality of
fatigue by measuring behavior/severity, affective meaning, sensory, and cognitive/mood
(Piper et al., 1998). Respondents rate each item on a scale of 0 to 10 and the overall scale
was found to be reasonable in time for completion (Piper et al., 1998). The Cronbach’s
alpha was retained at 0.92 after item reduction and the overall alpha coefficient was
reliable at 0.97 (Piper et al., 1998). Piper et al. recommended screening for fatigue with a
simple 0 to 10 severity rating and then further assessing those patients who report
moderate to severe fatigue using the revised PFS (Piper et al., 1998).
The PFS has been translated into multiple languages and the literacy demand for
most items is an eighth-grade education (Reeve et al., 2012). A main concern with the
PFS is respondent burden, so research has been done to reduce the number of items even
further (Reeve et al., 2012). This resulted in a 12-item fatigue scale (PFS-12) that was
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tested in a cohort of breast cancer survivors and found to be reliable and able to capture
multiple aspects of fatigue while being more brief (Reeve et al., 2012).
Galiano-Castillo et al. (2014) used a cross-sectional study to investigate the
association between depressed mood and physical activity, CRF, QOL, and fitness level.
CRF was measured using the PFS. The researchers found statistically positive
correlations between depressed mood and level of CRF. Having CRF, low physical
activity level, systematic side effects, and low body image were all predictors of
depressed mood. Limitations to this study include the limited inclusion criteria, no causal
relationship can be drawn, and the study did not consider other variables such as sleep
(Galiano-Castillo, Ariza-Garcia, Cantarero-Villanueva, Fernandez-Lao, Diaz-Rodriguez,
Arroyo-Morales, 2014).
Hall, Mishel, and Germino (2014) conducted a cross-sectional analysis to
investigate the relationship between survivorship-related functioning, fatigue, and
uncertainty in younger breast cancer survivors. The revised PFS was used. The
researchers concluded that fatigue is a persistent concern for survivors and is significantly
related to uncertainty. Limitations to this study include the inability to draw causal
relationship conclusions, and the use of self-report measures but no objective measures
(Hall, Mishel, & Germino, 2014).
Brief Fatigue Inventory
The Brief Fatigue Inventory (BFI) was developed in 1998 and was based on the
Brief Pain Inventory (BPI) with its simple wording and numerical scale from 0-10
(Mendoza et al., 1998). The BFI consists of 9 items and assesses how the fatigue
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interferes with general activity, mood, walking ability, normal work, relationships, and
enjoyment of life (Mendoza et al., 1998). This scale was tested against the POMS and
FACT-F scales and was found to be significantly correlated to each other (r = -0.88, p <
.001 for FACT and r = 0.84, p < .001 for POMS) (Mendoza et al., 1998). The BFI also
has internal consistency coefficient of 0.96. The scale is easily and quickly administered
in clinic or clinical trials (Mendoza et al., 1998). However, it does not capture the
multidimensional nature of fatigue and therefore may be most useful as a screening tool
with a cut-off of 7 denoting severe fatigue that warrants further, lengthier investigation
(Mendoza et al., 1998).
Mao et al. (2018) conducted a cross-sectional analysis of breast cancer survivors
on aromatase inhibitor (AI) therapy and the prevalence of fatigue. CRF was measured
using the BFI. The researchers concluded that 4 in 5 patients on AI experience fatigue
with 1 in 2 reporting moderate to severe fatigue. Limitations include potential for recall
bias, decreased generalizability since only assessed those on AI, the BFI is not
multidimensional, and with this design a causal relationship cannot be established (Mao
et al., 2018).
Smith et al. (2013) conducted a mixed method randomized controlled trial to
investigate acupuncture on CRF. The fatigue measurement tool was the BFI. The
researchers concluded that acupuncture is a feasible intervention and that the BFI is
sensitive to changes in CRF over time. This study was of higher quality being a
controlled trial and had good compliance with the intervention. However, recruitment
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was slow, the study sample was small, the study had a short duration, and there was
potential for a dose response bias (Smith, Carmady, Thornton, Perz, & Ussher, 2013).
Fatigue Symptom Inventory
The Fatigue Symptom Inventory (FSI) was developed in 1998 as a way to
measure fatigue intensity and duration (Hann et al., 1998). The respondents rate their
fatigue for the past week at its worst, least, and average on a 0-10 scale. It also consists of
a 7 item subscale that assesses the amount of interference the fatigue had on general
activity, activities of daily living, work, concentration, relationships, enjoyment, and
mood, again on a 0-10 scale (Hann et al., 1998). The alpha coefficients for the
interference subscale were high for each tested group (0.93-0.95). The test-retest
reliability correlations were not as strong ranging from 0.1-0.75 (Hann et al., 1998). The
FSI was correlated with the POMS, and SF-36. It was found to be acceptable to patients
with low respondent burden (Hann et al., 1998).
Again, Goedendorp et al. (2016) used a cross-sectional analysis to determine the
optimal cutoff scores for fatigue screening on the SF-36, FSI, and POMS-fatigue. On the
FSI higher ratings equates to greater severity or interference. The researchers concluded
that while all three scales are brief and accurate the FSI was found to be most accurate.
Limitations include a homogenous sample and that the results were cross-validated using
the same data from different time points (Goedendorp et al., 2016).
Multidimensional Fatigue Symptom Inventory-Short Form
The Multidimensional Fatigue Symptom Inventory-Short form (MFSI-SF) was
developed in 1998 to fill the need for a multidimensional scale (Stein, et al., 2004). It

39
consists of 30 items in 5 subscales measuring general fatigue, physical fatigue, emotional
fatigue, mental fatigue, and vigor. Each item is a self-report measure using a 5-point
Likert scale to indicate the extent to which the patient had the symptom the previous
week (Stein, et al., 2004). Reliability coefficients for the subscales were 0.96 for general,
0.85 for physical, 0.93 for emotional, 0.90 for mental, and 0.88 for vigor. The internal
consistency alpha coefficients for each subscale were 0.96 for general, 0.92 for
emotional, 0.87 for physical, 0.91 for mental, and 0.90 for vigor (Stein, et al., 2004). The
MFSI-SF had high to moderate correlation with the FSI and SF-36. Advantages of this
scale include the fact that it is multidimensional, not disease specific, it is brief, and has
ease of response (Stein, et al., 2004).
Stan et al. (2016). Conducted a pilot feasibility study to determine if a DVD
guided home based yoga intervention versus a strength training intervention improved
CRF and QOL. CRF was screened using the NCCN guidelines and then assessed in more
detail using the MFSI-SF. The researchers concluded that both the yoga DVD and
strength intervention were effective and feasible in improving CRF and QOL. Limitations
of this study include lack of a non-intervention (control) group. There was also a small
sample size, short follow-up period, lack of contact with the instructors, low adherence to
the treatment, and difference in length of the 2 interventions. These limitations contribute
considerably to bias and weaken the results (Stan et al., 2016).
Cancer Fatigue Scale
The Cancer Fatigue Scale (CFS) was developed in Japan in 1999 as a self-report,
brief, multidimensional measure of fatigue for cancer patients (Okuyama, et al. 2000).
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The scale consists of 15 items in 3 subscales of physical, affective, and cognitive
dimensions. The maximum score is 28 with higher scores meaning more severe fatigue
and average completion time is 132.9 seconds (Okuyama, et al. 2000). The Cronbach’s
alpha coefficient were 0.90 for the physical subscale, 0.78 for the affective subscale, 0.79
for the cognitive subscale, and 0.88 for the total scale. The CFS scores correlated with the
visual analog scale (VAS) for fatigue scores (average r = .49, p < .001). The internal
consistency coefficient was 0.89 for physical, 0.79 for affective, 0.79 for cognitive, and
0.77 for total scale. The test-retest correlation coefficient for each factor compared the
total score were all greater than 0.50 with a p < 0.001 (Okuyama, et al. 2000).
Kroz et al. (2014) conducted a prospective observational study to investigate the
effect of autonomic and self-regulation on CRF and distress. CRF was measured using
the CSF-D with reliability reported at Cronbach’s alpha of r = .84-.94 and test-rest
reliability of r = .73-.86. Distress was measured by the Hospital Anxiety and Depression
Scale (HADS). The researchers concluded that reduced risk of CRF co-occurs with high
autonomic regulation and high self-regulation is associated with reduced distress.
Limitations include small cohort sample, no causation can be established, presence of
selection bias with Caucasian only sample, and patient reported outcomes without
objective measures (Kröz et al., 2014).
In a different study, Kroz et al. (2017) conducted a cohort study to compare
multimodal therapy (mindfulness and behavioral training) in combination with aerobic
training to standard aerobic training alone to see which intervention had an effect on CRF
and sleep. The researchers measured fatigue using the CFS-D in German. The researchers
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found that multimodal was superior to aerobic therapy alone in reduction of CRF and
improvement in sleep. Limitations to this study include small sample size, high drop-out
rate, and use of the last-value-carried-forward technique. These limitations could lead to
bias and decrease in generalizability (Kröz et al., 2017).
Functional Assessment of Chronic Illness Therapy
The Functional Assessment of Chronic Illness Therapy (FACIT) is a
measurement system with a collection of questionnaires measuring different elements of
QOL (Cella, et al., 2003). The original version was the FACT, previously described,
developed in 1987. Now in its 4th version the FACIT-general questionnaire is used to
assess physical well-being, social/family well-being, emotional well-being, and
functional well-being (Cella, et al., 2003). The items on each subscale are rated on a 5point Likert scale with a high score being good. FACIT has been translated into 45
different languages. Most questionnaires within FACIT can be completed in 5 to 10
minutes. Contained within the FACIT scales collection are disease specific scales such as
anemia, breast cancer, and colorectal cancer (Cella, et al., 2003).
Lev-ari et al. (2013) conducted a descriptive study of a pilot program to
investigate the use of meditation in improving well-being. CRF was assessed using
FACIT. The researchers found an improvement in physical and mental health after
intervention. However, limitations include no control group, a modest sample size and
self-selected participants, no data over time, and reliance on self-report outcomes (Levari, Zilcha-Mano, Rivo, Geva, & Ron, 2013).
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Jones et al. (2016) conducted a cross-sectional analysis to investigate the
prevalence of CRF across time in breast, prostate, and colorectal cancer survivors. The
researchers used the FACIT scale. The researchers concluded that fatigue scores were
higher for breast and colorectal survivors but did not differ over time and that CRF can
persist 6 years posttreatment. CRF was also found to be highly associated with disability.
Limitations include the cross-sectional design which limits the ability to establish
causation (Jones et al., 2016).
Swen, Mann, Paxton, and Dean (2017) conducted a cross-sectional analysis to
determine the association between physical activity level and fatigue level in AfricanAmerican breast cancer survivors. The FACIT was used to measure fatigue. The
researchers found that less CRF was associated with more physical activity. This finding
applied mostly to younger survivors (less than 50 years old). Limitations include the
inability to establish a causal relationship, no differentiation between physical fatigue and
emotional fatigue, self-reported data makes it more prone to recall bias, and that the
FACIT scale was developed for those in active treatment, not cancer survivors (Swen,
Mann, Paxton, & Dean, 2017).
Numerical Severity Screening
In 2014, ASCO published clinical practice guidelines on the screening,
assessment, and management of fatigue in cancer survivors. The guideline was informed
by existing guidelines from the pan-Canadian guideline which was formed from
recommendations from the ONS and the NCCN (Bower, et al., 2014). ASCO
recommends screening all patients at least annually for CRF, more frequently if
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indicated. Screening is done using a numerical severity scale, 0 being no fatigue and 10
being worst fatigue in the last week (Bower, et al., 2014). Patients who score 4-10 on the
screening should then be further evaluated using a multisymptom tool. Included in the
guideline is a table listing the potential instruments for evaluating fatigue (Bower, et al.,
2014). The available unidimensional scales include FACT-F and POMS and the
multidimensional scales include BFI, FSI, MFSI-20 and 30, and the Revised PFS (Bower,
et al., 2014). Other scales mentioned in the guideline but not covered in this review
include the Schwartz Cancer Fatigue Scale, the Chalder Fatigue Scale, and the European
Organization for Research and Treatment of Cancer, Quality of Life Questionnaire
(EORTC-QLQ). The guideline goes on to detail the comprehensive physical assessment
along with potential interventions (Bower, et al., 2014).
In 2018, the NCCN issued updated survivorship guidelines with a section on
CRF. This guideline is similar to the ASCO guideline and recommends screening for
fatigue in every cancer survivor at least annually and as clinically indicated (NCCN,
2018). Screening is done using a numerical severity scale with 0 being no fatigue and 10
being worst fatigue over the previous week. Those that score 4-10 indicating moderate to
severe fatigue are then further evaluated with a comprehensive history and physical.
NCCN does not make a recommendation regarding the best assessment tool nor do they
list available assessment instruments (NCCN, 2018).
Analysis
The articles in the literature review are all examples of fatigue assessment tools
being used in the survivorship population. Most studies were cross-sectional analyses (7),
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with 1 mixed method-randomized controlled trial, and 1 each of cohort study, feasibility
study, descriptive study, and prospective observational study. The most commonly used
assessment tools include the FACIT used 3 times, CFS-D used twice, PFS used twice,
and the BFI also used twice. The MFSI-SF and the FACT-B were each used once.
Finally, 1 study used 3 assessment tools: SF-36, FSI, and POMS-Fatigue. (See Appendix
B)
The data analysis was conducted using the GRADE approach which consists of 5
basic steps. (See Table 1) First is to set a priori ranking based on the type of study
according to the hierarchy of evidence. (See figure 1) For example, a randomized
controlled trial is ranked high and an observational study would be ranked low. Second
step is to either upgrade or downgrade this priori ranking according to certain criteria. For
example, risk of bias would indicate a downgrade while a large consistent effect of
outcome could justify an upgrade. Third is to assign the final GRADE, either high,
moderate, low, or very low. Fourth is to take into consideration other factors such as costeffectiveness and patient preference. Finally, is to make a recommendation either strong
for using, weak for using, strong against using, or weak against using (Siemieniuk &
Guyatt, 2018).

45

Table 1
GRADE Process
Step 1:
A prior
ranking

Step 2:
Upgrade/downgrade

Step 3:
GRADE
assignment

Randomized
controlled
trial: HIGH

Downgrade for:
Risk of bias
Inconsistency
Indirectness
Imprecision
Publication bias

HIGH

Observational
study: LOW

MODERATE
LOW
VERY LOW

Upgrade for:
Large consistent
effect
Dose response
Confounders only
Reducing size of
effect

Step 4:
Consider factors
affecting
recommendation
Balance of
desirable and
undesirable
effects
Costeffectiveness
Preference of
patients

Step 5:
Make
recommendation
Strong for Using
Weak for using
Strong against
using
Weak against
using
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Higher

Lower
Systematic Reviews and
Meta-analyses of RCTs
Randomized Controlled Trials

Quality of

Cohort Studies

Evidence

Case-Controlled Studies

Risk of Bias

Cross-Sectional Studies; Surveys
Case Reports; Case Studies
Mechanistic Studies
Lower

Editorials; Expert Opinion

Higher

Figure 1. Hierarchy of evidence pyramid.

GRADE was applied to the 14 sources in the literature review matrix. Of these, I
assigned 4 an initially high ranking, 9 a moderate ranking, and 1 a low ranking. After
taking into consideration bias and limitations of each source the final GRADE consisted
of 2 high, 3 moderate, 8 low, and 1 very low. I considered other factors such as costeffectiveness, time efficiency, and ease of use for patients, reliability and validity of
scale, and multidimensional or single dimensions. Of the 14 sources, 2 are recommended
as strong for using, 6 are recommended as weak for using, and 6 are recommended as
weak against using. None are considered strong against using (see Table 2).

47
Table 2
GRADE Summary of Findings
Author(s),
year
NCCN,
2018

Rankinga Up/downgrade GRADE
High

None

High

Bower et
al., 2014

High

None

High

Kroz et al.,
2017

High

Down-bias
and
limitationsb

Mod

Stan et al.,
2016

Mod

Down-study
limitationsb

Low

GalianoCastillo et
al., 2014
Goedendorp
et al., 2016

Mod

Down-study
limitationsb

Low

Mod

Down-study
limitationsb

Low

Swen et al.,
2017

Mod

Low

Hall et al.,
2014

Mod

Down-bias
and
limitationsb
Down-study
limitationsb

Jones et al.,
2016

Mod

None

Low

Low

Other factors

Recommendation

Cost and time
effective.
Ease of
screening for
patients.
Cost and time
effective.
Ease of
screening for
patients.
Reliable scale
and valid
measures of
multiple
dimensions.
Reliable and
valid fatigue
scale.
Fatigue scale
with high
reliability.
Efficient
screening.
SF-36 has
reverse
worded
items.
None.

Strong for using

Validated
fatigue scale
for multiple
domains of
fatigue.
Scale
supported by

Fatigue
tool
Numerical
screening

Strong for using

Numerical
screening

Weak for using

CFS-D

Weak for using

MFSI-SF

Weak for using

Revised
PFS

Weak against
using

SF-36;
FSI;
POMSfatigue

Weak against
using

FACIT

Weak for using

Revised
PFS

Weak for using

FACIT
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Mao et al.,
2018

Mod

Down-bias
and
limitationsb

Low

Lev-ari et
al., 2013
Kroz et al.,
2014

Mod

Down-study
limitationsb
Down-bias
and
limitationsb

Low

Smith et al.,
2013

High

Low

Down-study
limitationsb

Very
low

Mod

psychometric
data.
Internal
consistency
of fatigue
scale.
None.
Fatigue scale
with good
reliability,
validity, and
test-retest
reliability.
Fatigue scale
with good
sensitivity to
change over
time.
None.

Weak against
using

BFI

Weak against
using
Weak against
using

FACIT

Weak for using

BFI

Kaur et al.,
Mod
Down-study
Low
Weak against
b
2018
limitations
using
Note. a Initial ranking is either high, moderate, low, or very low. b See literature review
table for study limitations.
The 2 sources considered strong for using with a high final GRADE include the
NCCN and ASCO guidelines. Both of these guidelines recommend initial screening of all
breast cancer survivors using a numerical severity scale with 4 being the cutoff to
indicated potentially clinically significant fatigue. Then further assessment using any
fatigue measurement instrument (Bower et al., 2014; NCCN, 2018). The fatigue
assessment tools used in the sources that received a weak for using recommendation
include the CFS-D, MFSI-SF, PFS, FACIT, and the BFI. PFS was recommended twice as
weak for using. The fatigue assessment tools using in the sources that received a weak
against using include the SF-36, FSI, POMS-fatigue, FACIT, BFI, FACIT, CFS-D, and

CFS-D

FACT-B
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FACT-b. The only assessment tool that received a ‘for using’ recommendation and did
not receive an ‘against using’ recommendation was the PFS.
An unanticipated outcome was the lack of current articles addressing this topic.
Other than the 2 clinical practice guidelines, all of the other sources were research using
fatigue assessment scales in breast cancer survivors, but none of the sources evaluated
which scale was the most appropriate to use. This limits their applicability to the question
at hand and limits the conclusions that can be drawn from the sources. Another
unanticipated outcome is that the 2 clinical practice guidelines made no recommendation
as to which fatigue assessment scale to use when more thorough and detailed assessment
is warranted. Leaving the decision up to the individual practitioner.
There are a few implications to address. On the individual level, the assessment of
fatigue can lead to a more accurate clinical picture of the situation and thus more targeted
interventions. For the community of breast cancer survivors, addressing fatigue in a
targeted purposeful way could help reduce the number of patient suffering from CRF and
improve the QOL for this population. For the institution, and health system as a whole,
improved QOL and less distressing symptoms for breast cancer survivors could mean a
decrease over-utilization of the health care system. Relieving the burden of CRF from
individual patients, the local breast cancer survivor population, and the university health
system. All of these potential implications can contribute to positive social change.
Recommendations
The results of this literature review support the use of the NCCN or ASCO
guidelines in the screening of fatigue. However, the review does not provide enough
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evidence to clearly support any specific follow up tool in the assessment of potentially
clinically significant cases of fatigue. Screening of all survivors at initial survivorship
visit and periodically thereafter using a numerical severity scale from 0-10 with 0 being
none and 10 being severe fatigue. This can be done during rooming for office visits,
similar to how the pain scale is used. If the score is 4 or greater then further evaluation is
warranted. Further evaluation can then be done with one the various tools described in
this review. See Appendix C for a summary of the tools.
Implementation would begin with education of the clinicians and nurses providing
survivorship care. Education would include background on the clinical problem,
necessity of screening and assessment, and education on use of the screening tool. Next
would be incorporating the screening into the electronic health record and into clinic
flow. Then, an important step to implementation is to receive feedback from patients and
staff and make adjustments in the process as necessary.
Strengths and Limitations of the Project
Strengths of the doctoral project include logical flow through the data collection,
practical organization of data, and use of a specific criteria for analyzing the data.
Another strength is the availability of high quality evidence in the form of 2 clinical
practice guidelines that address this topic. Conversely, the majority of sources discovered
in the literature review were cross-sectional studies which is of low priori ranking in
GRADE. Again, one of the limitations was the lack of sources that specifically addressed
the question, limiting their applicability to the question. Another limitation is the lack of
panel of reviewers applying the GRADE criteria. Panel consensus is stronger and more
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objective with different viewpoints coming to a decision together than an individual’s
viewpoint which can be subjective.
It is clear that more research needs to done on this topic. The various fatigue
scales and assessment tools need to be evaluated under more rigorous conditions to
reduce the bias and limitations found in this review and result in more reliable results.
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Section 5: Dissemination Plan
Dissemination
A few avenues exist for potential dissemination of my findings to the institution
and to the broader nursing profession. The information and conclusions from the
systematic review could be presented via PowerPoint or poster to the breast cancer care
team during the weekly breast team meetings. For the wider institution, dissemination
could be done through the weekly cancer institute grand rounds forum. For the statewide
cancer community, the information could be presented to the ACC through a poster at
their annual meeting. For national oncology nursing profession, the systematic review
could be submitted for publication through the ONS or APSHO.
Analysis of Self
I began this journey toward the DNP in January of 2016. I then began my career
in oncology in September of 2016. At that time, my mentor, being ever supportive of my
education and growth as a practitioner, presented a survivorship clinical problem: fatigue
interfering with sexual function in breast cancer survivors. My mentor then challenged
me to investigate this problem and I was not sure where to even begin. The journey
through this program has guided me in the pursuit of this clinical problem and has
prepared me to take on future problems as a scholar practitioner. My next goal is to
achieve certification in oncology advanced practice. Long-term professional goals would
be to grow the survivorship clinic to include other cancer survivors, such as melanoma
and colon, and to be able to provide a truly multidisciplinary clinic.
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This project was a daunting task. It involves many steps and pages of writing to
fully cover the scope of the issue and to thoroughly address the gap in practice. I certainly
experienced frustrations and delays throughout the quarters. Personal issues interfered
and then my own disorganization and procrastination interfered. Thankfully, my
committee chair was ever present to help me focus my premise, revise and fine tune my
proposal, and complete my data collection and analysis. Ultimately, I was prepared to
synthesis the data results and present my findings along with recommendations for
clinical practice and for future research. The process, although daunting at first, evolved
in an organic way.
Summary
This doctoral project is a culmination of doctoral study. It is a systematic review
of the literature, the purpose of which is to address a gap in nursing practice. The guiding
clinical practice question was: What is the best method of assessing CRF in breast cancer
survivors? The literature review and analysis revealed that no recommended assessment
tool exists in this population but rather suggestions of several different fatigue
measurement tools. The most robust evidence was for the use of the NCCN and ASCO
guidelines that recommend screening using a numerical severity scale and then further
assessing those patients who score 4 or greater. The further assessment can be done using
several different instruments and this review does not support the use of any 1 tool.
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PRISMA Flow Diagram
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Screening
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(n = 23)

Records excluded
(n = 9)

Full-text articles
assessed for eligibility
(n = 14)

Full-text articles
excluded
(n =0)

Studies included in
qualitative synthesis
(n =14)

From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews
and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed100009
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